Are Things Looking Up For Vanda Pharmaceuticals Inc (NASDAQ: VNDA)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Vanda Pharmaceuticals Inc is $264.11M. A total of 1.03 million shares were traded on the day, compared to an average of 1.00M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, VNDA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 6 BUYs and 16 SELLs from insiders. Insiders purchased 112,943 shares during that period but sold 147,282.

In the most recent transaction, Wijkstrom Joakim sold 3,724 shares of VNDA for 5.84 per share on Aug 21. After the transaction, the SVP, Chief Marketing Officer now owns 113,816 company shares. In a previous transaction on Aug 10, Mitchell Stephen Ray sold 6,500 shares at 6.05 per share. VNDA shares that Director owns now total 29,328.

Among the insiders who sold shares, Moran Kevin Patrick disposed of 2,212 shares on Jul 28 at a per-share price of $6.30. This resulted in the SVP, CFO & Treasurer holding 120,714 shares of VNDA after the transaction. In another insider transaction, Moran Kevin Patrick sold 16,000 shares at $6.29 per share on Jun 15. Company shares held by the SVP, CFO & Treasurer now total 122,926.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for VNDA in the last 3 months, the mean price target is $4.25 with high estimates of $4.25 and low estimates of $4.25. In terms of 52-week highs and lows, VNDA has a high of $7.00 and a low of $3.30.

As of this writing, VNDA has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of $0.05 per share and a lower estimate of $0.05. The company reported an EPS of $0 in the last quarter, which was 100.00% higher than expectations of -$0.04.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VNDA’s latest balance sheet shows that the firm has $432.81M in Cash & Short Term Investments as of fiscal 2021. There were $12.37M in debt and $74.42M in liabilities at the time. Its Book Value Per Share was $9.47, while its Total Shareholder’s Equity was $504.93M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VNDA is Buy with a score of 3.00.

Most Popular

Related Posts